Fast-moving consumer goods (FMCG) giant, Marico, on Monday, 9 February 2026, announced that the company’s subsidiary has entered into an agreement to acquire a majority stake in a Vietnam-based skin care company, Skinetiq, according to an exchange filing.
Shares of the FMCG giant will be in focus of the Indian stock market investors on Tuesday, 10 February 2026.
“Marico South East Asia Corporation (MSEA), a wholly owned subsidiary of Marico Limited, has entered into definitive agreements to make strategic investment in Skinetiq Joint Stock Company (Skinetiq), an entity incorporated in Vietnam, which owns the digital-first science-backed skin care brand Candid and holds exclusive distribution rights in Vietnam for the luxury clinical skincare brand Murad,” the company informed the stock exchanges.
Under the agreement, Marico’s subsidiary MSEA will acquire a 75% stake in Skinetiq for nearly ₹261.6 crore or 750 billion Vietnamese Dong via two tranches.
The first part of the deal, Marico’s subsidiary will pay ₹222.30 crore upon receiving 75% stake in the firm, and then the remaining ₹Rs 39.3 crore will be paid through the second tranche, subject to the fulfillment of certain terms and conditions under the definitive agreement.
Marico share price trend
Marico shares closed 0.03% higher at ₹753 after Monday’s trading session, compared to ₹752.75 at the previous trading session, according to the NSE data. The company announced the acquisition update after market operating hours on 9 February 2026.
Read all stories by Anubhav Mukherjee
Disclaimer: This story is for educational purposes only. We advise investors to consult with certified experts before making any investment decisions, as market conditions can change rapidly and circumstances may vary.
